Lijuan Shen1,2, Tingting Jiang1,3, Pengzhou Tang1,3, Huijuan Ge3,4, Chao You1,3, Weijun Peng1,3. 1. Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China. 2. Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 3. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 4. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Abstract
Background: Pure grouped amorphous calcifications are classified as Breast Imaging Reporting and Data System (BI-RADS) category 4B suspicious calcifications and recommended for biopsy. However, the biopsies often reveal benign findings, especially in screening mammograms (92.4-97.2%). Methods: Mammograms of 699 pure grouped amorphous calcifications with final pathological results were analyzed in this retrospective study. The maximum span (MS) of the group of calcifications and the MS of the parallel/vertical direction of the mammary duct (MPS/MVS) were measured, and the MPS to MVS ratio was calculated. Based on the MS and ratio, 2 prediction nomograms with other clinic-mammographic features were developed. The discrimination performance of the models was assessed and compared by the area under the receiver operating characteristic curve (AUC). Scatterplots were created to determine the cutoff values with fewer misdiagnoses of malignant calcifications and fewer false positives. Results: Ultimately, 2 prediction models were successfully developed based on the 4 risk factors of age, purpose of the mammogram, whether multiple or single calcifications, and the MS [odds ratio (OR) =1.06, P=0.02]/ratio (OR =6.05, P<0.001). Both models had good discrimination. The ratio model performed better than the MS model in the training cohort (AUC of 0.875 and 0.834, respectively, P=0.003) and validation cohort (AUC 0.908 and 0.867, respectively, P=0.047). For the group with probably benign calcifications (as detected by the ratio nomogram), the malignancy rates were 2.7% [95% confidence interval (CI): 1.00% to 6.53%] and 1.19% (95% CI: 0.06% to 7.37%) in the training and validation cohorts, respectively, and 44.12% and 47.70% of benign biopsies were detected in the training and validation cohorts, respectively. Conclusions: The clinico-mammographic quantitative malignancy risk prediction nomogram showed favorable discrimination and calibration performance. The ratio model showed better diagnostic efficiency than the MS model, and identified >40% of benign biopsies. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Background: Pure grouped amorphous calcifications are classified as Breast Imaging Reporting and Data System (BI-RADS) category 4B suspicious calcifications and recommended for biopsy. However, the biopsies often reveal benign findings, especially in screening mammograms (92.4-97.2%). Methods: Mammograms of 699 pure grouped amorphous calcifications with final pathological results were analyzed in this retrospective study. The maximum span (MS) of the group of calcifications and the MS of the parallel/vertical direction of the mammary duct (MPS/MVS) were measured, and the MPS to MVS ratio was calculated. Based on the MS and ratio, 2 prediction nomograms with other clinic-mammographic features were developed. The discrimination performance of the models was assessed and compared by the area under the receiver operating characteristic curve (AUC). Scatterplots were created to determine the cutoff values with fewer misdiagnoses of malignant calcifications and fewer false positives. Results: Ultimately, 2 prediction models were successfully developed based on the 4 risk factors of age, purpose of the mammogram, whether multiple or single calcifications, and the MS [odds ratio (OR) =1.06, P=0.02]/ratio (OR =6.05, P<0.001). Both models had good discrimination. The ratio model performed better than the MS model in the training cohort (AUC of 0.875 and 0.834, respectively, P=0.003) and validation cohort (AUC 0.908 and 0.867, respectively, P=0.047). For the group with probably benign calcifications (as detected by the ratio nomogram), the malignancy rates were 2.7% [95% confidence interval (CI): 1.00% to 6.53%] and 1.19% (95% CI: 0.06% to 7.37%) in the training and validation cohorts, respectively, and 44.12% and 47.70% of benign biopsies were detected in the training and validation cohorts, respectively. Conclusions: The clinico-mammographic quantitative malignancy risk prediction nomogram showed favorable discrimination and calibration performance. The ratio model showed better diagnostic efficiency than the MS model, and identified >40% of benign biopsies. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Entities:
Keywords:
Breast; amorphous calcification; mammography; nomogram; predictive value of tests
Authors: Benjamin Kaltenbach; Volker Brandenbusch; Volker Möbus; Gerhard Mall; Stephan Falk; Marcus van den Bergh; Frauke Chevalier; Markus Müller-Schimpfle Journal: Eur J Radiol Date: 2016-11-23 Impact factor: 3.528
Authors: Alexander A Bankier; Heber MacMahon; Jin Mo Goo; Geoffrey D Rubin; Cornelia M Schaefer-Prokop; David P Naidich Journal: Radiology Date: 2017-06-26 Impact factor: 11.105
Authors: Hayley C Oligane; Wendie A Berg; Andriy I Bandos; Sue S Chen; Sahand Sohrabi; Maria Anello; Margarita L Zuley Journal: Radiology Date: 2018-06-19 Impact factor: 11.105
Authors: Marnix A de Roos; Bert van der Vegt; Jaap de Vries; Jelle Wesseling; Geertruida H de Bock Journal: Ann Surg Oncol Date: 2007-04-24 Impact factor: 5.344
Authors: Vera Christina Camargo de Siqueira Ferreira; Elba Cristina Sá de Camargo Etchebehere; José Luiz Barbosa Bevilacqua; Nestor de Barros Journal: Radiol Bras Date: 2018 Mar-Apr